This weekend the CEO is delivering a presentation to 200 Sophisticated and Institutional Investors. Some would be taking an early position from their own DD prior to the rest of the room making an affirmative decision to climb on board, IMHO SNT is only gaining ground on its way to fair market value ,, 4 x Phase II , enough Cash to see out the trial runway till mid 2025.
Market Cap is on $52m My personal view is with Positive Data provided by the 4 Phase 1 Trials , Recruitment well underway , no objections from the DSMB Data Safety Monitoring Board, Remarkable Statement from the Principal Investigator, SNT should be circa $100m prior to December Data Presentation in the United Stares,, no one sets themselves up to fail on the Main Stage ,, Management are demonstrating confidence and in Biotech that’s usually derived from looking at the data in front of you ,, NZT Plus the CEO clearly stated “ There are plenty of Catalysts that the company have before years end”
SNT Price at posting:
4.4¢ Sentiment: Buy Disclosure: Held
